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Fatigue in Inflammatory Bowel Disease: Developing an understanding of the research need 
through a narrative review.  
 
Patients with Inflammatory Bowel Disease (IBD) are affected by a number of symptoms, undergo 
lifelong pharmacological treatments and clinical interventions. (Bennebroek Evertsz’ et al., 2012; 
O’Connor et al., 2013) Fatigue is one of the most experienced symptoms of patients with IBD, and 
has some of the largest impact on patients’ lives.(Czuber-Dochan, Ream and Norton, 2013) IBD 
related fatigue is only identified in a relatively small proportion of those affected. (Van Langenberg 
and Gibson, 2014; Williet et al., 2017) 
 
The complex aetiology of IBD fatigue, its subjective nature and the lack of a standardised measure of 
fatigue add to the challenge of developing suitable and effective management methods. (Simrén et 
al., 2008; Whitehead, 2009; Czuber-Dochan, Ream and Norton, 2013) IBD usually has an early onset 
and is a chronic, incurable, condition. It does not typically shorten lifespan, therefore addressing how 
patients deal with their disease is a principal aspect of care.(Graff, Walker and Bernstein, 2009) IBD is 
incurable and, owing to the physical and psychological impact of the disease, it significantly reduces 
patients health related quality of life.(Huppertz-Hauss et al., 2015) 
 
IBD fatigue is one of the top 5 research priorities highlighted by the Nurses European Crohn’s and 
Colitis organisation  (N-ECCO) due to its pervasiveness and it’s unclear aetiology.(Mowat et al., 2011; 
Dibley et al., 2017) Fatigue is an extremely common complaint among patients with chronic disease 
and has been identified as one of the most burdensome symptoms of IBD.(Stjernman et al., 2010; 
Dibley et al., 2017) Several studies have identified fatigue as one of the leading concerns of IBD 
patients.(Drossman et al., 1989; Casati and Toner, 2000; de Rooy et al., 2001)   Recently, the 
symptom of fatigue has received greater attention as part of overall health-related quality of life 
(HRQoL) assessments in patients with chronic disease, including IBD.(Swain, 2000) The subjective 
nature of fatigue, poor understanding and lack of proven therapies with which to treat, this symptom is 
often ignored or underestimated by clinicians. (Czuber-Dochan W1, Dibley LB, Terry H, Ream E, 
2013; Czuber-Dochan, Norton, Bredin, et al., 2014)  
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Fatigue related to LTC is defined as an ‘extreme and persistent sense of tiredness, weakness or 
exhaustion’(Dittner, Wessely and Brown, 2004) which can be physical, mental or both and is not 
easily resolved by sleep or rest.(Arnett and Clark, 2012) Fatigue can be attributed to both physical 
and mental exertion(Pawlikowska et al., 1994; Van’T Leven et al., 2010) or as the outcome of 
pathological processes.(Pawlikowska et al., 1994; Van’T Leven et al., 2010) The international 
classification of diseases code presents fatigue as an assortment of physical, cognitive and emotional 
symptoms affecting undertaking of daily tasks.(Elizabeth Haney, MD; M.E. Beth Smith, DO; Marian 
McDonagh, PharmD; Miranda Pappas, MA; Monica Daeges and Ngoc Wasson, MPH; and Heidi D. 
Nelson, MD, 2015) It is not known whether fatigue in a given disease is a result of being chronically ill 
or whether it represents a specific symptom of that disease.(Swain, 2000). Fatigue is often attributed 
to LTC conditions, however it is experienced by most people at some point in life and can usually be 
allied to excessive physical activity, stress or ill health.(Wu, Wyrwich and McSweeney, 2006) Fatigue 
is often the first symptom reported in acute physical or mental illness,(Minden, Orav and Reich, 1987; 
Dittner, Wessely and Brown, 2004; Radbruch et al., 2008) often preceding and following the period of 
illness.(Vollmer-Conna et al., 2004; Wu, Wyrwich and McSweeney, 2006) In LTC, fatigue can lead to 
a chronic psychological depletion of energy reserves and result in functional impairment (Romberg-
Camps et al., 2010), this type of fatigue which arises from a pathological process or psychological 
disorder of a longer duration is often referred to as chronic fatigue. IBD fatigue has been reported as 
multidimensional and complex, impacting individual’s activities of daily living and reducing their 
HRQoL.(Stjernman et al., 2010) 
 
Incidence and prevalence of IBD is increasing globally.(Wilson et al., 2010; Jussila et al., 2012; 
Molodecky et al., 2012) Historically IBD incidence has varied according to geographical location, with 
higher incidence in the western world being linked to industrialisation. However emerging data 
speculates that there is increasing incidence in eastern countries, potentially due to immigration, more 
westernised diets and lifestyles and better healthcare systems.(Sood et al., 2003; Thia et al., 2008) . 
In the UK it is estimated that there are 300,000 people affected by IBD. CD and UC affects  5-10 and 
10-20 new patients, respectively, per 100,000 people per year. (Topchiev et al., 2017) 
The causal relationship between chronic fatigue and diminished HRQoL is not completely understood, 
though an intricate interaction of several factors, such as pain, malnutrition, phycological distress, 
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sleep difficulties and ongoing inflammation is reportedly involved.(Graff et al., 2011; Goldenberg et al., 
2013) 
 
The prevalence of IBD fatigue is reported as 41-48% for patients in remission and 71-86% in patients 
with active disease.(Van Langenberg and Gibson, 2010; Czuber-Dochan et al., 2013) This was 
deduced from three studies where fatigue was measured as a secondary outcome, relating 
predominantly to level of disease activity, HRQoL or mental health (I.M. et al., 2003; Björnsson et al., 
2004; Minderhoud, Samsom and Oldenburg, 2007).  Since the publication of these results further 
studies have reported the prevalence of IBD fatigue, the findings of recent publications suggest that 
when disease is in remission, fatigue in UC varies from 22-36% , and 27-41% in CD.(Häuser et al., 
2005; Romberg-Camps et al., 2010; Graff et al., 2011; Jelsness-Jørgensen et al., 2011) In a 
population with mixed disease activity, fatigue prevalence was reported as 44-64%.(Lesage et al., 
2011; Römkens et al., 2011; Tinsley et al., 2011; Bager et al., 2012) Some studies have compared 
levels of fatigue in IBD with that reported in other LTC such as PSC (Björnsson et al., 2004) and  
Multiple Sclerosis (MS) (Bol et al., 2010). Similar levels of fatigue have been reported in these 
conditions when compared with IBD, one study suggesting the fatigue in MS shows similar 
characteristics to that observed in UC.(Bol et al., 2010) Despite the reported similarity of fatigue in 
IBD prevalence to that seen in other health conditions, as a symptom IBD fatigue has only recently 
begun to receive a similar level of attention in research and clinical practice.  
 
 
The reported prevalence of IBD fatigue may be confused by severe and complex IBD presentations. 
There is also the limitation of the use of different fatigue measurement scales and tools, with no clear 
cut off point to define fatigue that requires an intervention.  
A consensus on the standard care for IBD-related fatigue, particularly regarding screening and 
management, is non-existent.(Kreijne et al., 2016) Currently there are no clinical guidelines on how to 
measure IBD fatigue in practice. There is no cut-off point for diagnosing IBD fatigue using measures 
that have been validated in an IBD cohort, at present a diagnosis of IBD fatigue is at the discretion of 
the clinician. The IBD Fatigue scale (Czuber-Dochan, Norton, Bassett, et al., 2014) and the Functional 
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Assessment of Chronic Illness Therapy Scale (FACIT-F) (Tinsley et al., 2011) have been validated in 
an IBD cohort but are still not widely implemented and do not have diagnostic cut off points. 
 
Throughout the reviewed literature to date, different scales measuring types of IBD fatigue have been 
applied, the Multi-Dimensional Fatigue Inventory scale (MFI) being the most widely used (Smets et 
al., 1995). Alternately there are differing scales used to measure functioning in IBD patients. Some of 
these scales are symptom specific such as the Fatigue Impact Scale (FIS) (Fisk et al., 1994) whilst 
other focus on HRQoL measurements (Ware, John E., 1992). Alternatively there are some studies 
where the authors developed their own questionnaires (Hershfield, 2005; Tanaka and Kazuma, 2005; 
Joyce et al., 2008; Topchiev et al., 2017). Only the IBD questionnaire (IBDQ) was developed with an 
IBD cohort, however it is designed to measure quality of life  (QoL) rather than fatigue and 
encompasses just one question relating to fatigue and one other on energy levels (Irvine, 1999). 
Czuber-Dochan developed a questionnaire comprising of 41 questions, in collaboration with IBD 
patients for the assessment of fatigue and QoL.(Czuber-Dochan, Norton, Bassett, et al., 2014)  
 
Several studies report that the domains most strongly associated with fatigue are physical (functional, 
reduced activity), cognitive (mental, sensory) and emotional (motivational, mood). (Casati and Toner, 
2000; Whitehead, 2009; Czuber-Dochan, Ream and Norton, 2013) It is important that we consider 
fatigue within a biopsychosocial model of care and consider how different physical and psychological 
factors interact with each other as a cause for IBD fatigue.  
 
There is comprehensible positive association between disease activity and high levels of fatigue. 
(Jelsness-Jørgensen et al., 2012; Graff et al., 2013; Cohen et al., 2014; Kappelman et al., 2014; Van 
Langenberg and Gibson, 2014) Throughout the literature there are also other identifiable factors, both 
modifiable and not, contributing to IBD fatigue. These include such factors as malnutrition, sleep 
deprivation, muscle depletion and various vitamin and mineral deficiencies that are potentially linked 
to disease symptomology. Due to the severity of IBD, related psychological distress is also 
common.(Keeton, Mikocka-Walus and Andrews, 2014) The risk of developing depression or anxiety 
one year or less before diagnosis with UC suggests symptoms might be a pre-clinical manifestation of 
IBD. Most anxiety or depression diagnosed subsequent to diagnosis of IBD occurs during the year 
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after IBD is diagnosed, indicating that these somatic symptoms might be reactive to the diagnosis 
rather that playing any aetiological role in IBD development.(Kurina et al., 2001)  
 
Available epidemiological data demonstrates a high prevalence of psychological illness in IBD. In one 
study it was observed that depression was significantly commoner in IBD compared with controls, 
27.2% in CD and 12.3% in Controls, with anxiety being common in IBD than controls, 8% in CD and 
4.7% in controls.(Walker et al., 2008) These data indicate that depression is the more prevalent 
psychological co-morbidity when compared to anxiety disorders in these cohorts. These co-
morbidities potentially influence both the onset and clinical course of the disease.(Maunder and 
Levenstein, 2008) There is significant association between baseline anxiety and depression scores, a 
flare up of symptoms in IBD patients, and disease relapse at 12 and 18 months follow up.(Mittermaier 
et al., 2004) Similarly, higher depression scores at baseline in a sample of 100 patients treated with 
infliximab was associated with a lower rate of  disease remission.(Persoons et al., 2005) This 
suggests that improvements in depressive symptoms are not solely related to improvements in the 
course of IBD.(Szigethy et al., 2009) In a study comparing people with UC to people with other LTC, 
patients with UC reported significantly more worrying over disease complications, depression and 
embarrassment.(Lönnfors et al., 2014)(Rubin et al., 2010) 
 
Stress management techniques in CD have been shown to significantly reduce tiredness when 
compared to the standard of care.(García-Vega and Fernandez-Rodriguez, 2004) Lower 
psychological well-being has been independently associated with IBD related fatigue(Simrén et al., 
2008) and changes in fatigue over time.(Graff et al., 2013) Patients with IBD in remission who had 
self-directed personality traits were less tired when compared to those who did not show traits of a 
self-directed personality type.(Banovic et al., 2012) Individuals who were able to adapt their behaviour 
to fit the situation in accordance with their chosen goals have lower levels of fatigue when compared 
to those people who are not able to adapt.(Opheim, Fagermoen, Jelsness-Jørgensen, et al., 2014) 
Quantitative studies considering other LTCs identify a strong interaction between disease related 
fatigue and depression and emotional stress. (Mohr, Hart and Goldberg, 2003; Armes, Krishnasamy 
and Higginson, 2004; Fuller-Thomson and Nimigon, 2008) 
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Social isolation has been linked with depression in IBD, increased levels of social support led to 
improvements in social functioning and a comparative reduction in depression and fatigue (Mohr, Hart 
and Goldberg, 2003; Häuser et al., 2005; Tanaka and Kazuma, 2005). In a European, questionnaire 
based study, 48% of respondents felt that their life was significantly or somewhat affected socially by 
IBD symptoms, even when in remission.(Lönnfors et al., 2014) 35% of respondents felt like IBD 
prevented them from pursuing an intimate relationship, with 17% reporting that IBD has caused their 
relationship to end. The same study reported that 75% of participants reported absenteeism at work 
with the most common reason being fatigue. Relatives play in important role in the process of 
acceptance of fatigue, as their acceptance of and support in managing disease related symptoms, 
such as fatigue, are highly valued by IBD patients. (Beck et al., 2013) one study suggested that lower 
social support was related to decline in ‘vigour’ in individuals with UC (Tanaka and Kazuma, 2005), 
however these findings are not supported by more recent evidence. (Simrén et al., 2008; Opheim, 
Fagermoen, Bernklev, et al., 2014; Norton et al., 2015) 
 
The management of long-term conditions (LTC) such as IBD, is widely acknowledged as one of the 
principal challenges facing the 21st century National Health Service (NHS). An estimated 70% of the 
total health care expenditure in England is associated with 30% of the population who have one or 
more LTC.(House of Commons Health Committee, 2014) IBD treatment has improved mainly due to 
prescription medication, however this has brought around a significant increase in healthcare 
costs.(Marchetti and Liberato, 2014) The cost of care for IBD patients is estimated to be in the range 
of £631 - £762 per patient per year.(Buchanan et al., 2011) This suggests an overall annual cost to 
the NHS of up to £470 million, with earlier research estimating the annual average cost of care per 
patient to be as high as £3,000.(Luces and Bodger, 2006; Molodecky et al., 2012) 
 
Research on the pathogenesis of IBD related fatigue, effective measurement and its impact on IBD 
patients will allow the discovery of predictors of severe fatigue that requires clinical intervention, also 
the development of clear treatment pathways and structured support for IBD patients (Kreijne et al., 
2016). This has the potential to improve patients HRQoL, experience of healthcare engagement and 
reduce cost to the NHS by reducing inadequate or inappropriate testing or referrals and targeting 
effective interventions to the right people at the right time.  
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